← back to database
Early-stage healthcare and life-sciences investor focused on the convergence of biotechnology, neuroscience, nanotechnology, and AI applied to the brain and related health and industrial uses.
Stage focus
Specialization
Generalist / Specialist
Specialist
Investing team
Bruce Greenberg
Doug Siekierski
Eric M. AttiasManaging Partner
Frederic Batoua
Giulia MortillaAnalyst
Guillaume BouyouxVice President
K. Alataris
Karine Montluc
Louis MoulinVice President
Philippe Louisadat